PELTANOVÁ, Barbora, Hana HOLCOVÁ POLANSKÁ, Martina RAUDENSKÁ, Jan BALVAN, Jiří NAVRÁTIL, Tomáš VIČAR, Jaromír GUMULEC, Barbora ČECHOVÁ, Martin KRÄTER, Jochen GUCK, David KALFEŘT, Marek GREGA, Jan PLZÁK, Jan BETKA and Michal MASAŘÍK. mRNA Subtype of Cancer-Associated Fibroblasts Significantly Affects Key Characteristics of Head and Neck Cancer Cells. Cancers. Basel: MDPI, 2022, vol. 14, No 9, p. 1-21. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers14092286.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name mRNA Subtype of Cancer-Associated Fibroblasts Significantly Affects Key Characteristics of Head and Neck Cancer Cells
Authors PELTANOVÁ, Barbora (203 Czech Republic, belonging to the institution), Hana HOLCOVÁ POLANSKÁ (203 Czech Republic, belonging to the institution), Martina RAUDENSKÁ (203 Czech Republic, belonging to the institution), Jan BALVAN (203 Czech Republic, belonging to the institution), Jiří NAVRÁTIL (203 Czech Republic, belonging to the institution), Tomáš VIČAR (203 Czech Republic, belonging to the institution), Jaromír GUMULEC (203 Czech Republic, belonging to the institution), Barbora ČECHOVÁ (203 Czech Republic, belonging to the institution), Martin KRÄTER, Jochen GUCK, David KALFEŘT (203 Czech Republic), Marek GREGA (203 Czech Republic), Jan PLZÁK (203 Czech Republic), Jan BETKA (203 Czech Republic) and Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution).
Edition Cancers, Basel, MDPI, 2022, 2072-6694.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.200
RIV identification code RIV/00216224:14110/22:00125782
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/cancers14092286
UT WoS 000794813300001
Keywords in English cancer; HNSCC; cancer-associated fibroblasts; tumour microenvironment; cell stiffness
Tags 14110515, 14110518, CF CELLIM, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 19/7/2022 10:45.
Abstract
Head and neck squamous cell carcinomas (HNSCC) belong among severe and highly complex malignant diseases showing a high level of heterogeneity and consequently also a variance in therapeutic response, regardless of clinical stage. Our study implies that the progression of HNSCC may be supported by cancer-associated fibroblasts (CAFs) in the tumour microenvironment (TME) and the heterogeneity of this disease may lie in the level of cooperation between CAFs and epithelial cancer cells, as communication between CAFs and epithelial cancer cells seems to be a key factor for the sustained growth of the tumour mass. In this study, we investigated how CAFs derived from tumours of different mRNA subtypes influence the proliferation of cancer cells and their metabolic and biomechanical reprogramming. We also investigated the clinicopathological significance of the expression of these metabolism-related genes in tissue samples of HNSCC patients to identify a possible gene signature typical for HNSCC progression. We found that the right kind of cooperation between cancer cells and CAFs is needed for tumour growth and progression, and only specific mRNA subtypes can support the growth of primary cancer cells or metastases. Specifically, during coculture, cancer cell colony supporting effect and effect of CAFs on cell stiffness of cancer cells are driven by the mRNA subtype of the tumour from which the CAFs are derived. The degree of colony-forming support is reflected in cancer cell glycolysis levels and lactate shuttle-related transporters.
Links
FW03010186, research and development projectName: Nová biočipová a mikrofluidní diagnostika cirkulujících biomarkerů a farmakogenů u psychiatrických a onkologických onemocnění
Investor: Technology Agency of the Czech Republic, Subprograms 1 Technology leaders
GA18-03978S, research and development projectName: Efekt buněčné tuhosti a mikroprostředí jako prediktor odpovědi na léčbu karcinomů hlavy a krku
Investor: Czech Science Foundation
LM2018129, research and development projectName: Národní infrastruktura pro biologické a medicínské zobrazování Czech-BioImaging
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1133/2021, interní kód MUName: Od buňky k medicíně (Acronym: CELLVIEW)
Investor: Masaryk University
MUNI/A/1391/2021, interní kód MUName: Molekulární, buněčná, tkáňová a systémová patofyziologie vybraných komplexních nemocí (Acronym: KOMPLEX_PF)
Investor: Masaryk University
NV18-08-00229, research and development projectName: Interakce buněk nádorového mikroprostředí jako nový nástroj predikce účinnosti terapie nádorů hlavy a krku
Investor: Ministry of Health of the CR
PrintDisplayed: 13/7/2024 17:33